Global Computational Medicine and Drug Discovery Software Market was valued at US$ 5.72 Bn in 2017 and is expected to reach US$ 8.71 Bn by 2026, at a CAGR of 5.4% during a forecast period.
Computational medicine includes a combination of engineering, mathematics, and computer science. The main aim of this field is to grow computational models for molecular biology, anatomy of disease, physiology, and apply these models to increase patient care.
Drug discovery processes through which new medicines have been exposed. It includes different disciples such as chemistry, biology, and pharmacology.
The objective of the report is to present a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, industry-validated market data and projections with a suitable set of assumptions and methodology. The report also helps in understanding computational medicine and drug discovery software market dynamics, structure by identifying and analyzing the market segments and project the global market size. Further, report also focuses on competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence. The report also provides PEST analysis, PORTER’s analysis, SWOT analysis to address questions of shareholders to prioritizing the efforts and investment in near future to emerging segment in computational medicine and drug discovery software market.
Computational medicine and drug discovery software play a vital role in the development of drugs for several diseases such as cancer and other genetic disorders. Computational medicine also aids to detect the fault in the genes and consequently helps to predict the cause of the disease. Computational medicine and drug discovery software are used to realize the protein-protein interactions as well as protein-ligand interactions which makes it easier to catch the drug target. Computational medicine and drug discovery software market are estimated to witness a stable growth with growing research activities on drug designing and development. Given the usefulness in drug development, private as well as government companies are rising investment in R&D is expected to fuel growth in the computational medicine and drug discovery software market.
Drug discovery and development composed are the complete process of identifying a new drug and bringing it to market. Discovery may include screening of chemical libraries, identification of the active ingredient from a natural remedy or design resulting from a considerate of the target. Development includes studies on microorganisms and animals, clinical trials and ultimately regulatory support. The huge market share can be credited to the rising investments in R&D activities pertaining to drug discovery and development and disease modeling.
Asia Pacific is estimated to highest CAGR during the forecast period owing to increasing adoption of technological innovations in the field of medicine. The market is projected to grow strongly across developing nations including China, Japan, and India.
Scope of the Global Computational Medicine and Drug Discovery Software Market
Global Computational Medicine and Drug Discovery Software Market by Tools
• Software
• Databases
• Others
Global Computational Medicine and Drug Discovery Software Market by Application
• Drug Discovery & Development
• Disease Modeling
• Medical Imaging
• Others
Global Computational Medicine and Drug Discovery Software Market by Geography
• North America
• Europe
• Asia-Pacific
• Middle East & Africa
• South America
Key Players operating in the Global Computational Medicine and Drug Discovery Software Market
• Aurora Fine Chemicals LLC
• Biognos AB
• Certara LP.
• Compugen Ltd.
• Prosarix Ltd
• Simulations Plus, Inc.
• Schrodinger, LLC
• FQS Poland
• Labsolutions LLC
• Entelos Inc
• Crown Bioscience Inc
MAJOR TOC OF THE REPORT
Chapter One: Computational Medicine and Drug Discovery Software Market Overview
Chapter Two: Manufacturers Profiles
Chapter Three: Global Computational Medicine and Drug Discovery Software Market Competition, by Players
Chapter Four: Global Computational Medicine and Drug Discovery Software Market Size by Regions
Chapter Five: North America Computational Medicine and Drug Discovery Software Revenue by Countries
Chapter Six: Europe Computational Medicine and Drug Discovery Software Revenue by Countries
Chapter Seven: Asia-Pacific Computational Medicine and Drug Discovery Software Revenue by Countries
Chapter Eight: South America Computational Medicine and Drug Discovery Software Revenue by Countries
Chapter Nine: Middle East and Africa Revenue Computational Medicine and Drug Discovery Software by Countries
Chapter Ten: Global Computational Medicine and Drug Discovery Software Market Segment by Type
Chapter Eleven: Global Computational Medicine and Drug Discovery Software Market Segment by Application
Chapter Twelve: Global Computational Medicine and Drug Discovery Software Market Size Forecast (2019-2026)
Browse Full Report with Facts and Figures of Computational Medicine and Drug Discovery Software Market Report at: https://www.maximizemarketresearch.com/market-report/global-computational-medicine-and-drug-discovery-software-market/25395/
About Us:
Maximize Market Research provides B2B and B2C market research on 20,000 high growth emerging technologies & opportunities in Chemical, Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors.
Contact info:
Name: Lumawant Godage
Organization: MAXIMIZE MARKET RESEARCH PVT. LTD.
Email: sales@maximizemarketresearch.com
Contact: +91 20 6630 3320/ +919607065656/ +919607195908
Website: www.maximizemarketresearch.com
